← MEST AI Startup Programme HIGH Startup
Programme Research
MEST AI Startup Programme ·
Programme Site
MEDIUM confidence Researched 2026-08-04 21:04 · profile: startup
The MEST AI Startup Programme is an incubator by the Meltwater Entrepreneurial School of Technology (MEST) that funds and supports early-stage AI startups founded by African entrepreneurs, providing training, mentorship, and networking to help them scale. It exists to foster tech innovation and entrepreneurship in Africa, with a focus on AI-driven solutions.
- Founder must be African (e.g., Nigerian) and based in Africa or willing to relocate. - Startup must be AI-focused, with a clear application of AI/ML in the product or service. - Stage: early-stage (pre-seed/seed) with a prototype or MVP; proof-of-concept is a plus. - Team: strong technical and business capabilities; solo founders are considered but team dynamics matter. - Scalability: potential for large market impact and growth. - Coachability: openness to mentorship and program structure. - Innovation: novelty of the AI application and competitive advantage. - Business model: clarity on revenue generation and market fit.
Past cohorts include African founders building AI solutions across sectors like fintech, healthtech, agritech, and logistics. Typical winners are early-stage startups with a working prototype, a clear AI component, and a founder with strong domain expertise. Named examples are not available on the page, but MEST has a track record of supporting ventures like those in their alumni network.
The ideal applicant is an African founder with a technical background, building an AI-first startup with a validated prototype and a clear path to market. They should be coachable, have a scalable business model, and be ready to commit to an intensive incubation program.
For Eniola Olutogun, the strongest angle is to position the venture as an AI-first healthtech startup that leverages her unique pharmacist-ML engineer background to address drug resistance—a critical global health challenge. The venture's use of protein language models (ESM-2) and drug fingerprints is a clear AI innovation, and the proof-of-concept results (AUROC 0.804) demonstrate technical viability. Emphasize the African founder angle and the potential for impact in infectious disease and oncology, aligning with MEST's focus on AI and African entrepreneurship.
The venture is not yet incorporated, which may be a requirement for some incubators. The programme's focus on AI startups may not fully align with the venture's deep biotech/computational biology nature, which could be seen as too niche. Also, the founder is a solo founder, which may be a disadvantage if the programme values team diversity.
2026-08-04 20:22 · medium confidence
2026-08-03 02:32 · medium confidence